Evaluation of multi-modality treatment for the patients with advanced esophageal cancer

Hiroshi Saeki, Takefumi Ohga, Shuhei Ito, Motonori Futatsugi, Yasue Kimura, Yoshihiro Kakeji, Yoshihiko Maehara, Katsumasa Nakamura, Yoshiyuki Shioyama

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hyperthermia has been proved to be intensely cytotoxic to malignant cells when combined with anticancer agents and irradiation. We have applied hyperthermo-chemo-radio-therapy (HCR) using a radiofrequency system with an endotract electrode to the patients with advanced esophageal cancer. In this study, 132 patients with advanced esophageal cancer with invasion to the neighboring structures, who underwent non-curative operation, were analysed. The markedly effective cases was observed in 12.2% in HCR group, while in 2.5% in chemoradiotherapy (CR) group, microscopically. The survival rate of the HCR group was significantly better than that of the CR group (p < 0.05). Pre- and post-operative leukocytopenia caused by preoperative treatment was not found to be a risk factor of postoperative complication. It is important to continue to clarify the factors influencing the effectiveness of preoperative HCR in the future. We hope that HCR will play an even more important role in treatment of esophageal cancer.

Original languageEnglish
Pages (from-to)259-265
Number of pages7
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume93
Issue number12
Publication statusPublished - Jan 1 2002

Fingerprint

Esophageal Neoplasms
Radio
Chemoradiotherapy
Group Psychotherapy
Play Therapy
Therapeutics
Leukopenia
Antineoplastic Agents
Electrodes
Fever
Survival Rate

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Evaluation of multi-modality treatment for the patients with advanced esophageal cancer. / Saeki, Hiroshi; Ohga, Takefumi; Ito, Shuhei; Futatsugi, Motonori; Kimura, Yasue; Kakeji, Yoshihiro; Maehara, Yoshihiko; Nakamura, Katsumasa; Shioyama, Yoshiyuki.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 93, No. 12, 01.01.2002, p. 259-265.

Research output: Contribution to journalArticle

Saeki, H, Ohga, T, Ito, S, Futatsugi, M, Kimura, Y, Kakeji, Y, Maehara, Y, Nakamura, K & Shioyama, Y 2002, 'Evaluation of multi-modality treatment for the patients with advanced esophageal cancer', Fukuoka igaku zasshi = Hukuoka acta medica, vol. 93, no. 12, pp. 259-265.
Saeki, Hiroshi ; Ohga, Takefumi ; Ito, Shuhei ; Futatsugi, Motonori ; Kimura, Yasue ; Kakeji, Yoshihiro ; Maehara, Yoshihiko ; Nakamura, Katsumasa ; Shioyama, Yoshiyuki. / Evaluation of multi-modality treatment for the patients with advanced esophageal cancer. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2002 ; Vol. 93, No. 12. pp. 259-265.
@article{d69414d49b8f4949bd678ac506d46d73,
title = "Evaluation of multi-modality treatment for the patients with advanced esophageal cancer",
abstract = "Hyperthermia has been proved to be intensely cytotoxic to malignant cells when combined with anticancer agents and irradiation. We have applied hyperthermo-chemo-radio-therapy (HCR) using a radiofrequency system with an endotract electrode to the patients with advanced esophageal cancer. In this study, 132 patients with advanced esophageal cancer with invasion to the neighboring structures, who underwent non-curative operation, were analysed. The markedly effective cases was observed in 12.2{\%} in HCR group, while in 2.5{\%} in chemoradiotherapy (CR) group, microscopically. The survival rate of the HCR group was significantly better than that of the CR group (p < 0.05). Pre- and post-operative leukocytopenia caused by preoperative treatment was not found to be a risk factor of postoperative complication. It is important to continue to clarify the factors influencing the effectiveness of preoperative HCR in the future. We hope that HCR will play an even more important role in treatment of esophageal cancer.",
author = "Hiroshi Saeki and Takefumi Ohga and Shuhei Ito and Motonori Futatsugi and Yasue Kimura and Yoshihiro Kakeji and Yoshihiko Maehara and Katsumasa Nakamura and Yoshiyuki Shioyama",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "93",
pages = "259--265",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "12",

}

TY - JOUR

T1 - Evaluation of multi-modality treatment for the patients with advanced esophageal cancer

AU - Saeki, Hiroshi

AU - Ohga, Takefumi

AU - Ito, Shuhei

AU - Futatsugi, Motonori

AU - Kimura, Yasue

AU - Kakeji, Yoshihiro

AU - Maehara, Yoshihiko

AU - Nakamura, Katsumasa

AU - Shioyama, Yoshiyuki

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Hyperthermia has been proved to be intensely cytotoxic to malignant cells when combined with anticancer agents and irradiation. We have applied hyperthermo-chemo-radio-therapy (HCR) using a radiofrequency system with an endotract electrode to the patients with advanced esophageal cancer. In this study, 132 patients with advanced esophageal cancer with invasion to the neighboring structures, who underwent non-curative operation, were analysed. The markedly effective cases was observed in 12.2% in HCR group, while in 2.5% in chemoradiotherapy (CR) group, microscopically. The survival rate of the HCR group was significantly better than that of the CR group (p < 0.05). Pre- and post-operative leukocytopenia caused by preoperative treatment was not found to be a risk factor of postoperative complication. It is important to continue to clarify the factors influencing the effectiveness of preoperative HCR in the future. We hope that HCR will play an even more important role in treatment of esophageal cancer.

AB - Hyperthermia has been proved to be intensely cytotoxic to malignant cells when combined with anticancer agents and irradiation. We have applied hyperthermo-chemo-radio-therapy (HCR) using a radiofrequency system with an endotract electrode to the patients with advanced esophageal cancer. In this study, 132 patients with advanced esophageal cancer with invasion to the neighboring structures, who underwent non-curative operation, were analysed. The markedly effective cases was observed in 12.2% in HCR group, while in 2.5% in chemoradiotherapy (CR) group, microscopically. The survival rate of the HCR group was significantly better than that of the CR group (p < 0.05). Pre- and post-operative leukocytopenia caused by preoperative treatment was not found to be a risk factor of postoperative complication. It is important to continue to clarify the factors influencing the effectiveness of preoperative HCR in the future. We hope that HCR will play an even more important role in treatment of esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=0038529379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038529379&partnerID=8YFLogxK

M3 - Article

C2 - 12632630

AN - SCOPUS:0038529379

VL - 93

SP - 259

EP - 265

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 12

ER -